VEGFA and amyotrophic lateral sclerosis: Targeting of the hypoxia-response element in the VEGF gene leads to degeneration of motorneurons and intracerebroventricular delivery of VEGF-A in a rat model of ALS delays onset of motorneuron degeneration and prolongs survival [12], [14].